iBio - Die Impfstoffmaschine (Seite 637)
eröffnet am 16.03.11 21:21:25 von
neuester Beitrag 02.05.24 21:50:27 von
neuester Beitrag 02.05.24 21:50:27 von
Beiträge: 18.250
ID: 1.164.726
ID: 1.164.726
Aufrufe heute: 1
Gesamt: 2.207.362
Gesamt: 2.207.362
Aktive User: 0
ISIN: US4510337086 · WKN: A3E2GR · Symbol: IBIO
2,2100
USD
-1,78 %
-0,0400 USD
Letzter Kurs 01:37:56 NYSE Arca
Neuigkeiten
| TitelBeiträge |
|---|
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 18,620 | +56,73 | |
| 1,2730 | +53,19 | |
| 0,8500 | +49,10 | |
| 1,2791 | +30,51 | |
| 1,8500 | +29,37 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 48,76 | -17,68 | |
| 0,9400 | -21,67 | |
| 3,4800 | -28,40 | |
| 1,7000 | -31,17 | |
| 0,7928 | -41,71 |
Beitrag zu dieser Diskussion schreiben
Feedback
Die Formulierung ist wichtig (wie ich finde) ...
in combination with multiple adjuvants, proved beneficial given the results observed with IBIO-201 in preclinical studies,” said Tom Isett, Chairman & CEO of iBio. “While IBIO-201 produced significantly higher anti-spike neutralizing antibody titers than IBIO-200, we are still encouraged by the potential of IBIO-200.
...ich persönlich glaube sie werden 200 später "opfern", um 201 so richtig forcieren zu wollen
Meinungen dazu?
in combination with multiple adjuvants, proved beneficial given the results observed with IBIO-201 in preclinical studies,” said Tom Isett, Chairman & CEO of iBio. “While IBIO-201 produced significantly higher anti-spike neutralizing antibody titers than IBIO-200, we are still encouraged by the potential of IBIO-200.
...ich persönlich glaube sie werden 200 später "opfern", um 201 so richtig forcieren zu wollen
Meinungen dazu?
Nun ja,...die „News“ reichen heute mal zum traden, mehr aber auch nicht...die nächsten Tage sind wir wieder bei 1,70
Antwort auf Beitrag Nr.: 65.031.954 von Schlood am 09.09.20 14:48:42....
https://ir.ibioinc.com/press-releases/detail/135/ibio-to-adv…
https://ir.ibioinc.com/press-releases/detail/135/ibio-to-adv…
Antwort auf Beitrag Nr.: 65.031.960 von Christian1279 am 09.09.20 14:49:05iBio to Advance COVID-19 LicKM-Subunit Vaccine Candidate, IBIO-201
👍
👍
Trading Spotlight
news zu 201 sind raus
Habt ihr die News aus dem Hause Astra Zeneca mitbekommen? (sorry, link habe ich nicht zur hand)
WASHINGTON, United States (AFP) — Pharmaceutical company AstraZeneca said Tuesday it had “voluntarily paused” a randomized clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness.
The company, which is developing the drug alongside the University of Oxford, is a frontrunner in the global race for a Covid-19 vaccine.
“As part of the ongoing randomized, controlled global trials of the Oxford coronavirus vaccine, our standard review process was triggered and we voluntarily paused vaccination to allow review of safety data by an independent committee,” a spokesperson said.
WASHINGTON, United States (AFP) — Pharmaceutical company AstraZeneca said Tuesday it had “voluntarily paused” a randomized clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness.
The company, which is developing the drug alongside the University of Oxford, is a frontrunner in the global race for a Covid-19 vaccine.
“As part of the ongoing randomized, controlled global trials of the Oxford coronavirus vaccine, our standard review process was triggered and we voluntarily paused vaccination to allow review of safety data by an independent committee,” a spokesperson said.
Antwort auf Beitrag Nr.: 65.026.470 von occitania am 09.09.20 06:32:54Now that would be really sweet 
, "if" the rumour proves to be true
https://twitter.com/rumormurmurbuzz/status/13034748560595681…
, "if" the rumour proves to be truehttps://twitter.com/rumormurmurbuzz/status/13034748560595681…
Durchsuchen
